Published in Retrovirology on September 16, 2005
SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells. Retrovirology (2007) 3.51
The remarkable frequency of human immunodeficiency virus type 1 genetic recombination. Microbiol Mol Biol Rev (2009) 2.02
Restriction of HIV-1 replication in monocytes is abolished by Vpx of SIVsmmPBj. PLoS One (2009) 0.96
Accuracy estimation of foamy virus genome copying. Retrovirology (2009) 0.92
Impaired RNA incorporation and dimerization in live attenuated leader-variants of SIVmac239. Retrovirology (2006) 0.84
Regulation of primate lentiviral RNA dimerization by structural entrapment. Retrovirology (2008) 0.82
Cross-packaging of genetically distinct mouse and primate retroviral RNAs. Retrovirology (2009) 0.82
Current progress and challenges in HIV gene therapy. Future Virol (2011) 0.82
HIV-2 genomic RNA accumulates in stress granules in the absence of active translation. Nucleic Acids Res (2014) 0.77
Recovery of fitness of a live attenuated simian immunodeficiency virus through compensation in both the coding and non-coding regions of the viral genome. Retrovirology (2007) 0.77
Mechanistic differences between HIV-1 and SIV nucleocapsid proteins and cross-species HIV-1 genomic RNA recognition. Retrovirology (2016) 0.75
Cross- and Co-Packaging of Retroviral RNAs and Their Consequences. Viruses (2016) 0.75
In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science (1996) 28.95
A third-generation lentivirus vector with a conditional packaging system. J Virol (1998) 16.07
Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol (1997) 12.11
Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions. J Virol (1989) 6.11
Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science (2000) 3.89
Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J Virol (1997) 3.37
A new method for the rapid and long term growth of human neural precursor cells. J Neurosci Methods (1998) 3.35
Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type 1 particles. J Virol (1993) 2.17
The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain. Nat Biotechnol (2001) 1.75
Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation. J Virol (1998) 1.64
HIV-1 Gag-RNA interaction occurs at a perinuclear/centrosomal site; analysis by confocal microscopy and FRET. Traffic (2005) 1.46
Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther (2000) 1.36
Location of cis-acting signals important for RNA encapsidation in the leader sequence of human immunodeficiency virus type 2. J Virol (1997) 1.34
Optimized lentiviral vector production and purification procedure prevents immune response after transduction of mouse brain. Gene Ther (2003) 1.25
Mapping the encapsidation determinants of feline immunodeficiency virus. J Virol (2002) 1.18
Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus. Hum Gene Ther (2000) 1.18
Certification assays for HIV-1-based vectors: frequent passage of gag sequences without evidence of replication-competent viruses. Mol Ther (2003) 1.15
Lentivirus vectors using human and simian immunodeficiency virus elements. J Virol (1999) 1.15
Primate and feline lentivirus vector RNA packaging and propagation by heterologous lentivirus virions. J Virol (2001) 1.08
A human immunodeficiency virus type 1 pol gene-derived sequence (cPPT/CTS) increases the efficiency of transduction of human nondividing monocytes and T lymphocytes by lentiviral vectors. Hum Gene Ther (2002) 1.08
Lentiviruses in gene therapy clinical research. Gene Ther (2002) 1.06
Development of a sensitive assay for detection of replication-competent recombinant lentivirus in large-scale HIV-based vector preparations. Mol Ther (2003) 1.03
Neurospheres modified to produce glial cell line-derived neurotrophic factor increase the survival of transplanted dopamine neurons. J Neurosci Res (2002) 1.01
Stem cells as a potential treatment of neurological disorders. Curr Opin Pharmacol (2004) 0.98
Nonreciprocal pseudotyping: murine leukemia virus proteins cannot efficiently package spleen necrosis virus-based vector RNA. J Virol (1998) 0.96
The packaging signal of simian immunodeficiency virus is upstream of the major splice donor at a distance from the RNA cap site similar to that of human immunodeficiency virus types 1 and 2. J Gen Virol (2003) 0.95
Delineation of sequences important for efficient packaging of feline immunodeficiency virus RNA. J Gen Virol (2003) 0.93
Adeno-associated viral vector-mediated gene transfer of brain-derived neurotrophic factor reverses atrophy of rubrospinal neurons following both acute and chronic spinal cord injury. Neurobiol Dis (2004) 0.93
The use of a recombinant lentiviral vector for ex vivo gene transfer into the rat CNS. Neuroreport (2000) 0.93
Lentiviral vectors for gene delivery to normal and demyelinated white matter. Glia (2003) 0.86
Proteoglycans and brain repair. News Physiol Sci (2004) 0.82
Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature (2002) 8.22
Reactivation of ocular dominance plasticity in the adult visual cortex. Science (2002) 6.06
Contained power morcellation within an insufflated isolation bag. Obstet Gynecol (2014) 2.92
The high cost of free lunch. Obstet Gynecol (2007) 2.76
The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res Rev (2007) 2.42
Axonal protein synthesis and degradation are necessary for efficient growth cone regeneration. J Neurosci (2005) 2.42
Chondroitinase ABC treatment opens a window of opportunity for task-specific rehabilitation. Nat Neurosci (2009) 2.37
Can experiments in nonhuman primates expedite the translation of treatments for spinal cord injury in humans? Nat Med (2007) 2.29
Malarial anemia: of mice and men. Blood (2007) 2.27
Commercial pressures and professional ethics: troubling revisions to the recent ACOG Practice Bulletins on surgery for pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct (2009) 2.10
Assembly of a new growth cone after axotomy: the precursor to axon regeneration. Nat Rev Neurosci (2012) 2.07
Transcriptome analysis of embryonic and adult sensory axons reveals changes in mRNA repertoire localization. RNA (2010) 2.07
Refusals by pharmacists to dispense emergency contraception: a critique. Obstet Gynecol (2006) 2.03
Subcellular profiling reveals distinct and developmentally regulated repertoire of growth cone mRNAs. J Neurosci (2010) 2.02
Inhibiting glycosaminoglycan chain polymerization decreases the inhibitory activity of astrocyte-derived chondroitin sulfate proteoglycans. J Neurosci (2007) 1.99
Chondroitin sulphate proteoglycans in the CNS injury response. Prog Brain Res (2002) 1.70
The perils of commercially driven surgical innovation. Am J Obstet Gynecol (2009) 1.70
The ascending pharyngeal artery: branches, anastomoses, and clinical significance. AJNR Am J Neuroradiol (2002) 1.63
Animals lacking link protein have attenuated perineuronal nets and persistent plasticity. Brain (2010) 1.63
Promoting plasticity in the spinal cord with chondroitinase improves functional recovery after peripheral nerve repair. Brain (2007) 1.61
Inosine promotes recovery of skilled motor function in a model of focal brain injury. Brain (2007) 1.57
Atonal homolog 1 is required for growth and differentiation effects of notch/gamma-secretase inhibitors on normal and cancerous intestinal epithelial cells. Gastroenterology (2010) 1.52
Fetus-saving Caesarian rejection by pregnant woman: a case study. Surgery (2009) 1.51
Chondroitin sulfate proteoglycans in neural development and regeneration. Curr Opin Neurobiol (2005) 1.50
Building a bridge: engineering spinal cord repair. Exp Neurol (2002) 1.50
HIV-1 Gag-RNA interaction occurs at a perinuclear/centrosomal site; analysis by confocal microscopy and FRET. Traffic (2005) 1.46
Alpha9 integrin promotes neurite outgrowth on tenascin-C and enhances sensory axon regeneration. J Neurosci (2009) 1.46
Neu3 sialidase-mediated ganglioside conversion is necessary for axon regeneration and is blocked in CNS axons. J Neurosci (2014) 1.45
Ethical issues arising from the performance of pelvic examinations by medical students on anesthetized patients. Am J Obstet Gynecol (2004) 1.41
Sharing clinical photographs: Patient rights, professional ethics, and institutional responsibilities. Bull Am Coll Surg (2015) 1.41
Extracellular matrix and perineuronal nets in CNS repair. Dev Neurobiol (2011) 1.38
Composition of perineuronal net extracellular matrix in rat brain: a different disaccharide composition for the net-associated proteoglycans. J Biol Chem (2006) 1.36
Engineering an antibiotic to fight cancer: optimization of the novobiocin scaffold to produce anti-proliferative agents. J Med Chem (2011) 1.36
Regional specification of rodent and human neurospheres. Brain Res Dev Brain Res (2002) 1.34
Composition of perineuronal nets in the adult rat cerebellum and the cellular origin of their components. J Comp Neurol (2006) 1.31
Chondroitin sulfate proteoglycans and microglia prevent migration and integration of grafted Müller stem cells into degenerating retina. Stem Cells (2008) 1.31
Versican is upregulated in CNS injury and is a product of oligodendrocyte lineage cells. J Neurosci (2002) 1.29
The ability of axons to regenerate their growth cones depends on axonal type and age, and is regulated by calcium, cAMP and ERK. Eur J Neurosci (2005) 1.27
HIV Gag polyprotein: processing and early viral particle assembly. Trends Microbiol (2012) 1.26
Proteoglycans in the central nervous system: plasticity, regeneration and their stimulation with chondroitinase ABC. Restor Neurol Neurosci (2008) 1.26
Role of chondroitin sulfate proteoglycans in axonal conduction in Mammalian spinal cord. J Neurosci (2010) 1.24
Databases and information integration for the Medicago truncatula genome and transcriptome. Plant Physiol (2005) 1.23
Integrin activation promotes axon growth on inhibitory chondroitin sulfate proteoglycans by enhancing integrin signaling. J Neurosci (2011) 1.23
The role of local protein synthesis and degradation in axon regeneration. Exp Neurol (2009) 1.23
Bonding of primed zirconia ceramics: evidence of chemical bonding and improved bond strengths. Am J Dent (2012) 1.22
Therapeutic time window for the application of chondroitinase ABC after spinal cord injury. Exp Neurol (2007) 1.22
Kindlin-1 enhances axon growth on inhibitory chondroitin sulfate proteoglycans and promotes sensory axon regeneration. J Neurosci (2012) 1.21
Chondroitinase combined with rehabilitation promotes recovery of forelimb function in rats with chronic spinal cord injury. J Neurosci (2011) 1.20
'PACLIMS': a component LIM system for high-throughput functional genomic analysis. BMC Bioinformatics (2005) 1.20
How does chondroitinase promote functional recovery in the damaged CNS? Exp Neurol (2007) 1.20
Distribution and synthesis of extracellular matrix proteoglycans, hyaluronan, link proteins and tenascin-R in the rat spinal cord. Eur J Neurosci (2008) 1.19
Chronic spinal hemisection in rats induces a progressive decline in transmission in uninjured fibers to motoneurons. Exp Neurol (2009) 1.18
The astrocyte/meningeal cell interface is a barrier to neurite outgrowth which can be overcome by manipulation of inhibitory molecules or axonal signalling pathways. Mol Cell Neurosci (2003) 1.16
Rab11 and its effector Rab coupling protein contribute to the trafficking of beta 1 integrins during axon growth in adult dorsal root ganglion neurons and PC12 cells. J Neurosci (2010) 1.15
Astrocytes and oligodendrocytes can be generated from NG2+ progenitors after acute brain injury: intracellular localization of oligodendrocyte transcription factor 2 is associated with their fate choice. Eur J Neurosci (2009) 1.13
Combination treatment with anti-Nogo-A and chondroitinase ABC is more effective than single treatments at enhancing functional recovery after spinal cord injury. Eur J Neurosci (2013) 1.12
Upregulation of aggrecan, link protein 1, and hyaluronan synthases during formation of perineuronal nets in the rat cerebellum. J Comp Neurol (2007) 1.11
Chondroitin 6-sulphate synthesis is up-regulated in injured CNS, induced by injury-related cytokines and enhanced in axon-growth inhibitory glia. Eur J Neurosci (2005) 1.10
Chondroitinase ABC combined with neurotrophin NT-3 secretion and NR2D expression promotes axonal plasticity and functional recovery in rats with lateral hemisection of the spinal cord. J Neurosci (2011) 1.09
A potential role for bone morphogenetic protein signalling in glial cell fate determination following adult central nervous system injury in vivo. Eur J Neurosci (2007) 1.08
ARF6 directs axon transport and traffic of integrins and regulates axon growth in adult DRG neurons. J Neurosci (2012) 1.07
Schwann cell migration is integrin-dependent and inhibited by astrocyte-produced aggrecan. Glia (2010) 1.06
Chondroitinase ABC has a long-lasting effect on chondroitin sulphate glycosaminoglycan content in the injured rat brain. J Neurochem (2007) 1.06
Transplantation of Schwann cell line clones secreting GDNF or BDNF into the retinas of dystrophic Royal College of Surgeons rats. Invest Ophthalmol Vis Sci (2004) 1.06
Microchannel electrodes for recording and stimulation: in vitro evaluation. IEEE Trans Biomed Eng (2009) 1.05
Human immunodeficiency virus type 1 Gag polyprotein modulates its own translation. J Virol (2006) 1.02
Automated mechanical passaging: a novel and efficient method for human embryonic stem cell expansion. Stem Cells (2006) 1.02
Heparan sulphate proteoglycans in glia and in the normal and injured CNS: expression of sulphotransferases and changes in sulphation. Eur J Neurosci (2008) 1.02
Expression and glycanation of the NG2 proteoglycan in developing, adult, and damaged peripheral nerve. Mol Cell Neurosci (2003) 1.00
Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo. Basic Res Cardiol (2002) 1.00
The challenges of long-distance axon regeneration in the injured CNS. Prog Brain Res (2012) 1.00
Alterations of splenic architecture in malaria are induced independently of Toll-like receptors 2, 4, and 9 or MyD88 and may affect antibody affinity. Infect Immun (2008) 0.98
Sentinel node biopsy using a magnetic tracer versus standard technique: the SentiMAG Multicentre Trial. Ann Surg Oncol (2013) 0.98
Regulation of RPTPbeta/phosphacan expression and glycosaminoglycan epitopes in injured brain and cytokine-treated glia. Mol Cell Neurosci (2003) 0.98
Rev regulates translation of human immunodeficiency virus type 1 RNAs. J Gen Virol (2009) 0.97
In-gel probing of individual RNA conformers within a mixed population reveals a dimerization structural switch in the HIV-1 leader. Nucleic Acids Res (2013) 0.96
Depletion of perineuronal nets enhances recognition memory and long-term depression in the perirhinal cortex. J Neurosci (2013) 0.95
Combination treatment with chondroitinase ABC in spinal cord injury--breaking the barrier. Neurosci Bull (2013) 0.95
6-Sulphated chondroitins have a positive influence on axonal regeneration. PLoS One (2011) 0.95
Rev binds specifically to a purine loop in the SL1 region of the HIV-1 leader RNA. J Biol Chem (2003) 0.95
Limited growth of severed CNS axons after treatment of adult rat brain with hyaluronidase. J Neurosci Res (2003) 0.95
Perisynaptic chondroitin sulfate proteoglycans restrict structural plasticity in an integrin-dependent manner. J Neurosci (2012) 0.95
Optimal packaging of FIV genomic RNA depends upon a conserved long-range interaction and a palindromic sequence within gag. J Mol Biol (2010) 0.94
Astrocyte-produced ephrins inhibit schwann cell migration via VAV2 signaling. J Neurosci (2010) 0.94
Semaphorin 3A binds to the perineuronal nets via chondroitin sulfate type E motifs in rodent brains. J Biol Chem (2013) 0.93
Spinal cord repair: bridging the divide. Neurorehabil Neural Repair (2008) 0.93
SHAPE analysis of the FIV Leader RNA reveals a structural switch potentially controlling viral packaging and genome dimerization. Nucleic Acids Res (2011) 0.93
An experimental model of secondary progressive multiple sclerosis that shows regional variation in gliosis, remyelination, axonal and neuronal loss. J Neuroimmunol (2008) 0.93
Dimerisation of HIV-2 genomic RNA is linked to efficient RNA packaging, normal particle maturation and viral infectivity. Retrovirology (2007) 0.92
NG2 expression in glioblastoma identifies an actively proliferating population with an aggressive molecular signature. Neuro Oncol (2011) 0.92
In vitro modeling of perineuronal nets: hyaluronan synthase and link protein are necessary for their formation and integrity. J Neurochem (2010) 0.92
Characterization of tests of functional recovery after median and ulnar nerve injury and repair in the rat forelimb. J Peripher Nerv Syst (2007) 0.91
Two separate metalloproteinase activities are responsible for the shedding and processing of the NG2 proteoglycan in vitro. Mol Cell Neurosci (2005) 0.91
2008 Nobel prize in medicine for discoverers of HIV. Retrovirology (2008) 0.91
Three-dimensional RNA structure of the major HIV-1 packaging signal region. Structure (2013) 0.91
Extrinsic and intrinsic factors controlling axonal regeneration after spinal cord injury. Expert Rev Mol Med (2009) 0.91
The chemorepulsive axon guidance protein semaphorin3A is a constituent of perineuronal nets in the adult rodent brain. Mol Cell Neurosci (2013) 0.91
Ethics in surgery. Curr Probl Surg (2013) 0.91
Modification of N-glycosylation sites allows secretion of bacterial chondroitinase ABC from mammalian cells. J Biotechnol (2009) 0.90
Controlled release of chondroitinase ABC from fibrin gel reduces the level of inhibitory glycosaminoglycan chains in lesioned spinal cord. J Control Release (2010) 0.89